Diagnostic impacts of DBT and ABVS for breast cancer screening in comparison with MMG and HUS

Nachiko Uchiyama; Naohisa Matsuda; Shoichiro Tsugane; Mari Kikuchi; Masahiko Kusumoto

doi:10.1117/12.2560096

22 May 2020 Diagnostic impacts of DBT and ABVS for breast cancer screening in comparison with MMG and HUS

Nachiko Uchiyama, Naohisa Matsuda, Shoichiro Tsugane, Mari Kikuchi, Masahiko Kusumoto

Proceedings Volume 11513, 15th International Workshop on Breast Imaging (IWBI2020); 115130F (2020) https://doi.org/10.1117/12.2560096
Event: Fifteenth International Workshop on Breast Imaging, 2020, Leuven, Belgium

Abstract

2427 women (mean age 60.0 years; range 20-94 years) were screened with DBT and ABVS from May 2014 to December 2018. 5375 women (mean age 57.3 years; range 40-84 years) were screened with MMG and HUS from February 2004 to December 2013. Number of recall cases (rate), unidentified cases, further exams, identified outcome cases, breast cancer cases, false positive cases, positive predictive value (PPV), cancer detection rate, implementation rate of further exams (fine needle aspiration (FNA), core needle biopsy (CNB), vacuum-assisted breast biopsy(VAB)) were evaluated between two groups. The recall rate was lower in women with DBT and ABVS in comparison with women with MMG and HUS (7.9 % vs 8.2%; p>0.05). Detection rate of breast cancers was higher in women with DBT and ABVS than women with MMG and HUS (1.6% vs 1.2%; p>0.05). Non-cancer rate among women receiving invasive procedures was lower in women with DBT and ABVS in comparison with women with MMG and HUS (0.9% vs 1.0%; p>0.05). PPV was significantly higher in women with DBT and ABVS in comparison with women with MMG and HUS (19.9% vs 14.5%; p=0.045). DBT and ABVS screening improved the cancer detection rate with significant higher PPV in comparison with MMG and HUS for breast cancer screening.

Citation Download Citation

Nachiko Uchiyama, Naohisa Matsuda, Shoichiro Tsugane, Mari Kikuchi, and Masahiko Kusumoto "Diagnostic impacts of DBT and ABVS for breast cancer screening in comparison with MMG and HUS", Proc. SPIE 11513, 15th International Workshop on Breast Imaging (IWBI2020), 115130F (22 May 2020); https://doi.org/10.1117/12.2560096

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available